Two Cases Where Pharmaceutical Marketing Machines Failed the Consumer
The sad truth, of course, is that this is not always the case. Let’s look at two such cases. First, consider the drug Neurontin. Neurontin was produced as an anti-convulsant drug, which had the potential to help a lot of people with seizure disorders. But the testing of the product was manipulated in order to sell it quickly, and it was marketed for unapproved uses such as headaches. Or consider Yaz birth control, a famous case in which the marketing left some specific details about side effects out of key advertisements. Many people died because of side effects from Yaz before these were reported to the general public, and lawsuits sprang up all across the United States in response to the misleading ads. Eventually the advertisements were fixed, but at what cost? These cases demonstrate a clear existence of a big pharmaceutical marketing machine, in which sales and figures take precedent over public health. Granted, not all pharmaceutical companies behave this way, but considering that studies show that marketing budgets far outweigh research budgets, one has to wonder what is happening to an industry that so many of us rely on. If you’re worried about what you’re taking, do some research and talk to your doctor about the risks of your medication. Remember: just because it’s prescribed doesn’t mean it is the right medicine for you. More on drugs and the FDA: http://www.good-legal-advice.com/dangerous_drugs.htm Disclaimer: Article submitters are solely responsible for the content of their articles. ArtiLib can't be held liable for the contents of the articles. Report Abuse | Browse By Category |
| Contact ArtiLib| Privacy Policy| Terms of Service |